Universe Pharmaceuticals Stock Analysis

Universe Stock Analysis Notes

The company has Price to Book (P/B) ratio of 0.11. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Universe Pharmaceuticals recorded a loss per share of 76.35. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 18th of November 2024. Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited. Universe Pharmaceuticals is traded on NASDAQ Exchange in the United States. For more information please call Gang Lai at 86 79 6840 3309 or visit https://www.universe-pharmacy.com.

Universe Pharmaceuticals Investment Alerts

Universe Pharmaceuticals Upcoming and Recent Events

Universe Stock Institutional Investors

Note, although Universe Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Universe Market Capitalization

The company currently falls under 'Nano-Cap' category with a total capitalization of 3.04 M.

Universe Profitablity

The company has Net Profit Margin of (0.69) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.14) %, which entails that for every $100 of revenue, it lost $0.14.

Management Efficiency

Universe Pharmaceuticals has Return on Asset of (0.0565) % which means that on every $100 spent on assets, it lost $0.0565. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.5022) %, meaning that it generated no profit with money invested by stockholders. Universe Pharmaceuticals' management efficiency ratios could be used to measure how well Universe Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of November 26, 2024, Return On Tangible Assets is expected to decline to -0.13. The current year's Return On Capital Employed is expected to grow to -0.1. At present, Universe Pharmaceuticals' Intangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.01, whereas Total Assets are forecasted to decline to about 47.2 M.

Technical Drivers

As of the 26th of November, Universe Pharmaceuticals has the Variance of 161.34, risk adjusted performance of (0.21), and Coefficient Of Variation of (343.86). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Universe Pharmaceuticals, as well as the relationship between them.

Universe Pharmaceuticals Price Movement Analysis

Universe Pharmaceuticals Insider Trading Activities

Universe Pharmaceuticals Outstanding Bonds

Universe Pharmaceuticals Predictive Daily Indicators

Universe Pharmaceuticals Forecast Models

Universe Pharmaceuticals' time-series forecasting models are one of many Universe Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Universe Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Universe Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Universe shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Universe Pharmaceuticals. By using and applying Universe Stock analysis, traders can create a robust methodology for identifying Universe entry and exit points for their positions.

When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.